As part of the FDA's rolling review of the biologics license application, Vertex expects to submit the first module to the regulator for potential accelerated approval before the end of 2025, and said ...
Capital requirements are standardized regulations for banks and other depository institutions that govern the capital, as a percentage of their assets, that they must maintain. Having this capital on ...
Vertex Inc. (NASDAQ: VERX) announced the launch of Kintsugi powered by Vertex, a new AI-native tax automation solution ...
Vertex Pharmaceuticals Incorporated has recently witnessed a notable change in its stock holdings, with Aberdeen Group plc ...